Health-related quality of life (HRQL) in VERTU: A randomized phase II trial of veliparib (V), radiotherapy (RT), and temozolomide (TMZ) for newly diagnosed MGMT unmethylated (uMGMT) glioblastoma (GBM).

被引：1
|
作者：
Sim, Hao-Wen
Barnes, Elizabeth
Lwin, Zarnie
Rosenthal, Mark
Wheeler, Helen
Koh, Eng-Siew
Foote, Matthew C.
Fisher, Lauren
Leonard, Robyn
Hall, Merryn
Simes, John
Khasraw, Mustafa
机构：
[1] St Vincents Hosp Sydney, Kinghorn Canc Ctr, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[3] Dept Med Oncol, Brisbane, Qld, Australia
[4] Royal Melbourne Hosp, Parkville, Vic, Australia
[5] Royal North Shore Hosp, Dept Oncol, St Leonards, NSW, Australia
[6] Liverpool Hosp, Liverpool, Merseyside, Australia
[7] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[8] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[9] COGNO Consumer Advisory Panel, Sydney, NSW, Australia
[10] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[11] Univ Sydney, Royal North Shore Hosp, St Leonards, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.2042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2042
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SAFETY RESULTS FROM AVAglio, A PHASE III RANDOMIZED STUDY OF BEVACIZUMAB (BEV) PLUS STANDARD COMBINATION TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    Chinot, Olivier L.
    Henriksson, Roger
    Mason, Warren
    Wick, Wolfgang
    Nishikawa, Ryo
    Dahr, Sunita
    Hilton, Magalie
    Garcia, Josep
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2013, 15 : 127 - 128
  • [32] NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress
    Khasraw, Mustafa
    McDonald, Kerrie L.
    Yip, Sonia
    Verhaak, Roel
    Heimberger, Amy
    Hall, Merryn
    Fisher, Lauren
    Barnes, Elizabeth
    Rosenthal, Mark
    Gedye, Craig
    Hovey, Elizabeth
    Ellingson, Benjamin M.
    Simes, John
    Tongela, Annette
    Wheeler, Helen
    Koh, Eng-Siew
    Gan, Hui
    Back, Michael
    Lwin, Zarnie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 196 - 197
  • [33] NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS
    Khasraw, Mustafa
    McDonald, Kerrie
    Yip, Sonia
    Verhaak, Roel
    Heimberger, Amy
    Hall, Merryn
    Fisher, Lauren
    Barnes, Elizabeth
    Rosenthal, Mark
    Gedye, Craig
    Hovey, Elizabeth
    Ellingson, Benjamin
    Simes, John
    Tognela, Annette
    Koh, Eng-Siew
    Gan, Hui
    Back, Michael
    Lwin, Zarnie
    NEURO-ONCOLOGY, 2018, 20 : 235 - 235
  • [34] Hypofractionated accelerated radiotherapy (HART) with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM)
    Mallick, Supriya
    Haresh, K. P.
    Gupta, Subhash
    Sharma, Seema
    Laviraj, M. A.
    Upadhyay, Ashish Dutt
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter
    Faye, M. D.
    Sabri, S.
    De Robles, P.
    Agnihotram, R.
    Torres-Vasquez, A.
    Panet-Raymond, V.
    Shenouda, G.
    Souhami, L.
    Esaw, J.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S169 - S169
  • [36] A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.
    Sampson, John H.
    Omuro, Antonio Marcilio Padula
    Preusser, Matthias
    Lim, Michael
    Butowski, Nicholas A.
    Cloughesy, Timothy Francis
    Strauss, Lewis C.
    Latek, Robert Raymond
    Paliwal, Prashni
    Weller, Michael
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.
    Ranjan, Tulika
    Peters, Katherine B.
    Vlahovic, Gordana
    Alderson, Lloyd M.
    Herndon, James Emmett
    McSherry, Frances
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    Desjardins, Annick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Phase II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma (GBM): Results of RTOG 0513
    Brachman, D. G.
    Wang, M.
    Ashby, L. S.
    Thomas, T. A.
    Dunbar, E. M.
    Rockhill, J. K.
    Khuntia, D.
    Bovi, J. A.
    Macher, M. S.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S129 - S130
  • [39] Health-related quality of life (HRQoL) in AVAglio, a randomized, placebo (P)-controlled phase III study of bevacizumab (B), temozolomide (T) and radiotherapy (RI) in patients (pts) with newly diagnosed glioblastoma (GBM)
    Bottomley, A.
    Henrikkson, R.
    Taphoorn, M. J. B.
    Cloughesy, T.
    Wick, W.
    Mason, W.
    Saran, F.
    Nishikawa, R.
    Ravelo, A.
    Chinot, O. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S780 - S780
  • [40] HEALTH-RELATED QUALITY OF LIFE AND NEUROCOGNITIVE STATUS IN PATIENTS WITH GLIOBLASTOMA MULTIFORME TREATED ON A PHASE II TRIAL OF HYPOFRACTIONATED RADIOTHERAPY WITH TEMOZOLOMIDE
    Reddy, Krishna
    Gaspar, Laurie
    Kavanagh, Brian
    Waziri, Allen
    Chen, Changhu
    NEURO-ONCOLOGY, 2012, 14 : 158 - 159
12345